BioStem Technologies, Inc. (OTCMKTS:BSEM) Sees Significant Growth in Short Interest

BioStem Technologies, Inc. (OTCMKTS:BSEM) was the target of a large growth in short interest in December. As of December 15th, there was short interest totalling 137,800 shares, a growth of 17.1% from the November 30th total of 117,700 shares. Based on an average trading volume of 120,600 shares, the days-to-cover ratio is currently 1.1 days.

BioStem Technologies Stock Performance

BSEM traded down $0.83 on Tuesday, hitting $11.99. The company had a trading volume of 53,414 shares, compared to its average volume of 38,395. The stock has a market capitalization of $199.63 million, a price-to-earnings ratio of 17.63 and a beta of -0.62. The stock has a fifty day moving average price of $15.85 and a 200-day moving average price of $12.09. BioStem Technologies has a 12-month low of $4.41 and a 12-month high of $28.26.

BioStem Technologies (OTCMKTS:BSEM) last posted its earnings results on Tuesday, November 12th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.31 by $0.01. The firm had revenue of $82.56 million for the quarter, compared to analysts’ expectations of $78.22 million. Analysts forecast that BioStem Technologies will post 1.41 EPS for the current fiscal year.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.